One of Pharma Manufacturing magazine’s Pharma Innovation Award winners is DeltaV Spectral Process Analytic Technology (PAT) which helps pharma and biopharma manufacturers build a foundation for better regulatory management while optimizing facility performance and throughput.
In just the last 10 years, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming much rarer, making way for multi-enterprise manufacturing collaborations and partnerships to better meet the changing needs of the...
Emerson offers an integrated Spectral PAT solution for DeltaV, allowing manufacturers to pursue closed-loop control (and real-time quality assessments) using in-line spectroscopic instruments.
The days of maintaining paper records across the life sciences development and production pipeline are gone. Today’s regulatory requirements, not to mention the complexity of new treatments, requires organization that can only be provided electronically. However,...
There can be little question that Industry 4.0 technologies are reshaping the way life sciences companies operate. In the wake of the rapid development of vaccines during the COVID-19 pandemic, more facilities than ever are being “born digital.” Some of these...
The life sciences marketplace is changing faster than nearly any other industry. Gone are the days when companies focus on a single treatment to drive their entire business. Today’s life sciences manufacturers are challenged to bring new treatments to the marketplace...
Christian Berg describes some solutions and technologies which facilitate the pursuit of the adaptive plant for manufacturers in the Life Sciences industry, as defined by the BioPhorum Digital Plant Maturity Model.
The BioPhorum Operations Group (BPOG) established a digital plant maturity model (DPMM) for biopharmaceutical manufacturing to define stages of factory evolution “from simple paper-based plants through to the fully automated and integrated ‘adaptive plant’ of the future.” The model gives organizations a common tool for industry comparison and measurement of progress. It also provides a platform to facilitate collaboration within the life sciences industry and its technology providers.
One of the key stages delaying and increasing costs in life sciences projects is equipment validation. In fact, it is one of the elements of project completion that project teams are most eager to compress because the value of every incremental improvement is so...
In BioPhorum’s MES of the Future Manifesto, Sean and Kate Porter collaborated with other biomanufacturing leaders on requirements for future Manufacturing Execution Systems.
In a Process Instrumentation article, How to ensure reliable pressure transmitter measurement in pharmaceutical applications, Emerson’s Brandon Haschke shares how “Advanced hygienic pressure transmitters can reduce downtime and operating costs thanks to long-term stability that requires fewer calibrations.”
Emerson’s Christian Berg presented Are We There Yet? Tackling Manufacturing Challenges with the Digital Plant at the Pharma Manufacturing World Summit in Boston.
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.